Bujanov Moscow City Clinical Hospital, Moscow, Russia.
Institute of Higher Nervous Activity and Neurophysiology, Moscow, Russia.
Metab Brain Dis. 2021 Dec;36(8):2473-2482. doi: 10.1007/s11011-021-00837-x. Epub 2021 Sep 24.
Dysphagia and progressive swallowing problems due to motoneuron death is one of amyotrophic lateral sclerosis (ALS) symptoms. Malnutrition and body weight loss result in immunological disturbances, fatigability and increase risk of secondary complications in ALS patients, percutaneous endoscopic gastrostomy tube (PEG) placement representing a well-recognized method for malnutrition correction and potentially increasing life expectancy. However, despite nutritional correction, occasional rapid neurological deterioration may develop after PEG placement. We have hypothesized that this decline can be a result of exteroceptive stress during PEG placement and promote neurodegeneration in ALS patients. Intravenous sedation may decrease stress during invasive procedures and it is safe during PEG placement in ALS patients. The aim of the study was comparing different PEG placement protocols of anesthesia (local anesthesia or local anesthesia plus intravenous sedation) in ALS from perspectives of stress load and neurological deterioration profile. During 1.5 years 94 ALS patients were admitted; gastrostomy was performed in 79 patients. After screening according to inclusion and exclusion criteria, 30 patients were included in the prospective consecutive study. All patients were divided in two groups, with local anesthesia and with combination of local anesthesia and intravenous sedation. Routine biochemical indices, neurodegeneration and stress markers were measured. The age of ALS patients was 61 ± 10 years; 20 patients were included at stage 4A and 10 at stage 4B (King's College staging). PEG was placed at average14 months after the diagnosis and 2.2 years after first symptoms. Mean ALS Functional Rating Scale-Revised was 27.8, mean forced vital capacity of lung 46.3% (19-91%). After one year of observation only 8 patients survived. Mean life duration after PEG was 5 months (5 days-20 months). Comparison of two PEG placement protocols did not reveal differences in survival time, stress load and inflammation level. Higher saliva cortisol levels, serum cortisol, glucose, C-reactive protein and interleukin-6 were detected after PEG placement, confirming considerable stress response. PEG is a stressful factor for ALS patients, PEG placement representing a natural model of exteroceptive stress. Stress response was detected as increased cortisol, C-reactive protein, interleukin-6, and glucose levels. Intravenous sedation did not increase the risk of PEG placement procedure, however, sedation protocol did not affect stress load.
由于运动神经元死亡导致的吞咽困难和进行性吞咽问题是肌萎缩侧索硬化症(ALS)的症状之一。营养不良和体重减轻会导致 ALS 患者免疫紊乱、疲劳,并增加继发并发症的风险,经皮内镜下胃造口术(PEG)是一种公认的纠正营养不良和潜在延长生存期的方法。然而,尽管进行了营养纠正,PEG 放置后偶尔仍会出现快速神经功能恶化。我们假设这种下降可能是由于 PEG 放置过程中外感受性应激导致的,并促进 ALS 患者的神经退行性变。静脉镇静可减少侵袭性操作过程中的应激,在 ALS 患者中进行 PEG 放置时是安全的。本研究的目的是比较不同麻醉方案(局部麻醉或局部麻醉联合静脉镇静)在 ALS 患者中 PEG 放置的应激负荷和神经恶化情况。在 1.5 年期间,94 例 ALS 患者入院;79 例患者进行了胃造口术。经过纳入和排除标准筛选后,30 例患者被纳入前瞻性连续研究。所有患者分为两组,一组采用局部麻醉,一组采用局部麻醉联合静脉镇静。测量常规生化指标、神经退行性变和应激标志物。ALS 患者的年龄为 61±10 岁;20 例患者处于 4A 期,10 例患者处于 4B 期(金斯学院分期)。PEG 在诊断后平均 14 个月和首次症状后 2.2 年放置。平均 ALS 功能评定量表修订版为 27.8,平均肺活量为 46.3%(19-91%)。观察 1 年后仅有 8 例患者存活。PEG 后平均生存时间为 5 个月(5 天-20 个月)。两种 PEG 放置方案的比较未发现生存时间、应激负荷和炎症水平的差异。PEG 放置后唾液皮质醇、血清皮质醇、葡萄糖、C 反应蛋白和白细胞介素-6 水平升高,证实存在较大的应激反应。PEG 是 ALS 患者的应激因素,PEG 放置是外感受性应激的自然模型。应激反应表现为皮质醇、C 反应蛋白、白细胞介素-6 和葡萄糖水平升高。静脉镇静并未增加 PEG 放置过程的风险,然而,镇静方案并未影响应激负荷。